A nicotineC-oxidase gene (CYP2A6) polymorphism important for promoter activity
- 9 February 2004
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 23 (3) , 258-266
- https://doi.org/10.1002/humu.20002
Abstract
In humans, several polymorphic variants have been described for the gene encoding the major nicotine C‐oxidase, cytochrome P450 2A6 (CYP2A6), which is to a great extent responsible for the large interindividual differences seen at the enzymatic and activity levels. Hitherto, mainly polymorphic variants in the open reading frame have been identified. In the present study, we identified a novel single nucleotide polymorphism (SNP) located in the 5′ flanking region of the CYP2A6 gene. Sequencing of 1.4 kb of the 5′‐upstream region of the CYP2A6 gene from eight individuals revealed a c.‐1013A>G polymorphism defining two new alleles, CYP2A6*1D and CYP2A6*1E, lacking or having also the CYP2A7 3′‐UTR. Analysis of genomic DNA from 32 Swedish and 109 Turkish subjects by dynamic allele‐specific hybridization (DASH) showed that, in both groups, the variants carrying the c.‐1013A>G SNP represent approximately 70% of the total number of alleles. Transfection of HepG2 cells with luciferase reporter constructs containing 1019 bp of the CYP2A6 5′‐regulatory sequence showed that the region between c.‐1005 and c.‐1019 elicited a strong enhancer effect and that the CYP2A6*1D promoter had significantly reduced expression as compared to CYP2A6*1A carrying c.‐1013A. Electrophoretic mobility shift assays (EMSA) showed that nuclear proteins from HepG2 and B16A2 cells exhibited a higher binding affinity to the probe harboring c.‐1013A as compared to the c.‐1013G probe, although the transcription factor(s) responsible for this binding could not be identified. In conclusion, our results indicate the presence of a strong enhancer or promoter responsive element between c.‐1005 and c.‐1019 in the CYP2A6 gene and that a c.‐1013A>G polymorphism in this region affects CYP2A6 transcription. Hum Mutat 23:258–266, 2004.Keywords
Funding Information
- Swedish Research Council
- Swedish Cancer Society
- Karolinska Institutet
- NIH (NIGMS 1-R01, GM60548-01A2)
This publication has 25 references indexed in Scilit:
- Cloning ofCYP2J2Gene and Identification of Functional PolymorphismsMolecular Pharmacology, 2002
- Nicotine metabolism and CYP2A6 allele frequencies in KoreansPharmacogenetics, 2001
- Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4 CPharmacogenetics, 2000
- Genetic Polymorphism in the 5'-Flanking Region of HumanCYP1A2 Gene: Effect on the CYP1A2 Inducibility in HumansThe Journal of Biochemistry, 1999
- Dynamic allele-specific hybridizationNature Biotechnology, 1999
- A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3 -pyridyl)thiazolidin-4-one hydrochloride (SM-12502)Pharmacogenetics, 1998
- The -104G nucleotide of the human CYP21 gene is important for CYP21 transcription activity and protein interactionNucleic Acids Research, 1998
- trans ‐Acting Factors, Detoxication Enzymes and Hepatitis B Virus Replication in a Novel Set of Human Hepatoma Cell LinesEuropean Journal of Biochemistry, 1996
- Close linkage of the cytochrome P450IIA gene subfamily (Cyp2a) to Cyp2b and Coh on mouse chromosome 7Genomics, 1990
- Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nucleiNucleic Acids Research, 1983